Provisional Timetable
(Subject to change: The conference may finish slightly earlier or later than the advertised time)
Event type: In-person only
Presentation language: English
Venue: The Jarvis Doctorow Hall, St Edmund Hall, Queen’s Lane, Oxford, UK
Time Zone: All times mentioned refer to British Standard (BST) – London/GMT +01:00.
Password: Registered conference delegates will be sent joining information a few days before the conference.
Wednesday 03rd September
0930: Registration
0925: Welcome and housekeeping
Morning Keynotes
09.30: KEYNOTE: Professor John Oxford, Queen Mary, London, UK
Viruses with respiratory transmission
1000: KEYNOTE: Professor Paul Kellam, Imperial College London, London, UK, and RQ Biotechnology Ltd, London, UK
Neutralising monoclonal antibodies for Emerging Viral Threats: Providing Instant Immunity
1030: KEYNOTE: Professor Teresa Lambe OBE, University of Oxford, Oxford, UK
TBA
1100: Coffee Break
1130: Dr Alessandra Ruggiero, University of Verona, Verona, Italy
Impact post-translational modifications (PTMs) on emerging respiratory viruses infectivity and vaccine responsiveness
1150: Dr Richard Urbanowicz, Liverpool School of Tropical Medicine, UK
The long arm of immunity: bovine antibodies with a broad viral reach
1210: Dr Diego Cantoni, University of Glasgow, Glasgow, UK
Emerging AI vs emerging viruses
1230: Professor Nigel Temperton and Dr Kelly da Costa, University of Kent, UK
Influenza pseudotypes: A masterclass
1300: Lunch Break
1400: KEYNOTE: Professor Thushan de Silva, University of Sheffield, Sheffield, UK
Dissecting respiratory virus ecology and immunity in The Gambia
1430: Dr Alexander Tarr, University of Nottingham, Nottingham, UK
Lectins enhance ebolavirus entry through interactions with specific N-linked glycans, resulting in conformational changes to the glycoprotein complex
1450: Dr Giada Mattiuzzo, MHRA, UK
Outbreak ready: a system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay
1510: Coffee Break
ECR talks
1545: Ms Asmaa Nasr, Lancaster University, UK
Unlocking Viral Replication: ACE2 Allows Bat HKU5-CoV to Thrive in Rousettus aegyptiacus (RE) bat cells
1600: Miss Fatima Ezzohra Ezahedi, University of Pécs, Pécs, Baranya, Hungary
Molecular epidemiology of SARS-CoV-2 in Algeria
1615: Miss Krisztina Leiner, University of Pécs, Pécs, Hungary
Novel nucleoside analogues as potential broad-spectrum antivirals against Alphaviruses
1630: Dr Noemi Guerrini, VisMederi Srl, Siena, Italy
Generation and optimisation of human papillomavirus pseudotypes
Evening session
1645: Dr Simon Scott, University of Kent, Kent, UK
TBA
1705: Dr Gabor Kemenesi, University of Pécs, Pécs, Hungary
Lesser known and rare zoonotic viruses
1735: END
1800 onwards: Informal dinner and Oxford historic public house tour
